As of 2025-04-30, the Relative Valuation of Jounce Therapeutics Inc (JNCE) is (11.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.88 USD, the upside of Jounce Therapeutics Inc based on Relative Valuation is -698.2%.
The range of the Relative Valuation is (8.57) - (15.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.4x - 16.0x | 11.3x |
| Forward P/E multiples | 8.9x - 16.0x | 12.0x |
| Fair Price | (8.57) - (15.44) | (11.25) |
| Upside | -555.9% - -921.3% | -698.2% |
| Date | P/E |